145 related articles for article (PubMed ID: 38055097)
1. Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan.
Komatsu H; Ikeda Y; Kawana K; Nagase S; Yoshino K; Yamagami W; Tokunaga H; Kato K; Kimura T; Aoki D; Obstetrics TCOGOOTJSO; Gynecology
Int J Clin Oncol; 2024 Jan; 29(1):72-77. PubMed ID: 38055097
[TBL] [Abstract][Full Text] [Related]
2. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
4. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
[TBL] [Abstract][Full Text] [Related]
5. [FIGO 2018 staging of cervical cancer and related issues].
Wang JD; Kong WM; Jiang H
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):94-98. PubMed ID: 32135641
[TBL] [Abstract][Full Text] [Related]
6. Validation of the 2018 FIGO cervical cancer staging system.
Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
[TBL] [Abstract][Full Text] [Related]
7. Clinical statistics of gynecologic cancers in Japan.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
[TBL] [Abstract][Full Text] [Related]
9. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Mikami M; Enomoto T; Katabuchi H; Aoki D
J Gynecol Oncol; 2020 Jul; 31(4):e45. PubMed ID: 32026659
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
12. Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain.
Salvo G; Odetto D; Pareja R; Frumovitz M; Ramirez PT
Int J Gynecol Cancer; 2020 Jun; 30(6):873-878. PubMed ID: 32241876
[TBL] [Abstract][Full Text] [Related]
13. Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.
Sehnal B; Kmoníčková E; Sláma J; Tomancová V; Zikán M
Klin Onkol; 2019; 32(3):224-231. PubMed ID: 31216857
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countries-Survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology.
Fuglsang K; Haldorsen IS; Avall-Lundqvist E; Lindahl G; Roed H; Woie K; Pakarinen P; Thoroddsen A; Anttila M; Blaakaer J
Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1178-1184. PubMed ID: 29799176
[TBL] [Abstract][Full Text] [Related]
15. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
Hricak H; Gatsonis C; Chi DS; Amendola MA; Brandt K; Schwartz LH; Koelliker S; Siegelman ES; Brown JJ; McGhee RB; Iyer R; Vitellas KM; Snyder B; Long HJ; Fiorica JV; Mitchell DG; ;
J Clin Oncol; 2005 Dec; 23(36):9329-37. PubMed ID: 16361632
[TBL] [Abstract][Full Text] [Related]
16. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014.
Yoshino K; Kurita T; Takahashi F; Nagase S;
J Obstet Gynaecol Res; 2022 Jul; 48(7):1570-1579. PubMed ID: 35633031
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
[TBL] [Abstract][Full Text] [Related]
18. Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013.
Aoki D
J Obstet Gynaecol Res; 2014 Feb; 40(2):338-48. PubMed ID: 24472052
[TBL] [Abstract][Full Text] [Related]
19. Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study.
Shigeta S; Shimada M; Tsuji K; Watanabe Z; Tanase Y; Matsuo K; Nakanishi T; Saito T; Aoki D; Mikami M
Sci Rep; 2023 Jul; 13(1):12020. PubMed ID: 37491468
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
